Alembic says Aleor JV gets final FDA approval for Metronidazole Gel USP, 1 %
Alembic Pharmaceuticals said that its joint venture Aleor Dermaceuticals has secured final approval for Metronidazole Gel USP, 1 % from the US Food and Drug Administration (FDA) for its abbreviated new drug application (ANDA). According to Alembic Pharmaceuticals, the approved ANDA is the therapeutical equivalent to the reference listed drug product (RLD) — Metrogel Gel, […]